Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    dasatinib AND GIST | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib

Study has passed its completion date and status has not been verified in more than two years.